Alerts will be sent to your verified email
Verify EmailTATVA
Tatva Chintan Pharma
|
Vishnu Chemicals
|
Camlin Fine Sciences
|
|
---|---|---|---|
Operational Metrics
|
|||
Chemical Sector
|
|||
Capacity Utilization - Chemicals - Reactor
|
64.11 % | n/a | n/a |
Pharmaceutical Sector
|
|||
Total reactor capacity
|
552.0 kL | n/a | n/a |
Financials
|
|||
5 yr Average ROE
|
13.1 % | 21.61 % | -0.75 % |
5yr average Equity Multiplier
|
1.4 | 2.69 | 2.29 |
5yr Average Asset Turnover Ratio
|
0.62 | 1.03 | 0.81 |
5yr Avg Net Profit Margin
|
11.89 % | 7.92 % | -0.61 % |
Price to Book
|
4.46 | 3.52 | 3.97 |
P/E
|
460.26 | 25.41 | 0.0 |
5yr Avg Cash Conversion Cycle
|
137.87 Days | 3.08 Days | 30.19 Days |
Inventory Days
|
121.92 Days | 77.46 Days | 107.15 Days |
Days Receivable
|
72.59 Days | 66.09 Days | 67.17 Days |
Days Payable
|
79.07 Days | 148.85 Days | 122.28 Days |
5yr Average Interest Coverage Ratio
|
11.05 | 4.76 | 2.4 |
5yr Avg ROCE
|
15.09 % | 21.95 % | 13.22 % |
5yr Avg Operating Profit Margin
|
17.59 % | 15.1 % | 12.42 % |
5 yr average Debt to Equity
|
0.24 | 0.95 | 0.82 |
5yr CAGR Net Profit
|
-35.78 % | 29.71 % | n/a |
5yr Average Return on Assets
|
8.28 % | 8.35 % | -0.48 % |
Shareholdings
|
|||
Promoter Holding
|
72.02 % | 69.21 % | 49.1 % |
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
Change in Promoter Holding (3 Yrs)
|
-7.15 % | -5.79 % | 31.54 % |
Change in Mutual Fund Holding (3 Yrs)
|
-5.27 % | 4.7 % | -10.13 % |
Tatva Chintan Pharma
|
Vishnu Chemicals
|
Camlin Fine Sciences
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Segment Break-Up
|
Segment Break-Up
|
-
|
-
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|